Literature DB >> 24185192

Synthesis, characterization and application of epichlorohydrin-β-cyclodextrin polymer.

Bina Gidwani1, Amber Vyas2.   

Abstract

Cyclodextrins, the macrocyclic compounds are renowned for their inclusion ability. Several chemical and polymerized derivatives of parent cyclodextrins are synthesized to improve the physicochemical/biopharmaceutical properties of drug and inclusion capacity of cyclodextrin. This review article recapitulates the potential aspects of polymerized water-soluble derivative of β-cyclodextrin viz. epichlorohydrin-β-cyclodextrin polymer in different areas of drug delivery. Polymerized cyclodextrin combines the advantage of the properties of polymer (high molecular weight and higher solubility) with the formation of inclusion complex with cyclodextrin. This justifies the superiority of polymerized cyclodextrin over parent cyclodextrin and some other chemically modified and non-polymerized derivatives. The use of polymerized cyclodextrin in various fields like biomedical, pharmaceutical and gene delivery is increasing day-by-day. β-Cyclodextrin-epichlorohydrin polymer is a high molecular weight compound, which acts as an effective drug carrier for enhancing the solubility and oral bioavailability of drugs along with the increase in therapeutic efficiency. The future panorama of polymerized cyclodextrins is quite bright as they can serve as useful multifunctional tools for pharmaceutical scientists to develop and optimize drug delivery through various routes. Also, no information concerning the regulatory status and toxicity of polymerized cyclodextrins is available. So, there is a need to focus on these critical issues for resolving the problems associated with the development and commercialization of drug products.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; Epichlorohydrin-β-cyclodextrin; Host–guest interaction; Hydrophilic; Polymerized cyclodextrin

Mesh:

Substances:

Year:  2013        PMID: 24185192     DOI: 10.1016/j.colsurfb.2013.09.035

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  20 in total

1.  Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy.

Authors:  Maurizio Viale; Rita Tosto; Valentina Giglio; Giuseppe Pappalardo; Valentina Oliveri; Irena Maric; Maria Addolorata Mariggiò; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2018-12-17       Impact factor: 3.850

2.  Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity.

Authors:  Maurizio Viale; Graziella Vecchio; Massimiliano Monticone; Vittorio Bertone; Valentina Giglio; Irena Maric; Michele Cilli; Vittorio Bocchini; Aldo Profumo; Mirco Ponzoni; Laura Emionite; Mattia Rocco
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

3.  New doxorubicin nanocarriers based on cyclodextrins.

Authors:  Maurizio Viale; Valentina Giglio; Massimiliano Monticone; Irena Maric; Giovanni Lentini; Mattia Rocco; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2017-04-04       Impact factor: 3.850

4.  Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells.

Authors:  Lingling Xu; Chuan Zhou; Fan Wang; Huiqin Liu; Guangyuan Dong; Siyi Zhang; Tao Liu
Journal:  RSC Adv       Date:  2022-06-17       Impact factor: 4.036

5.  Cyclodextrin polymers as nanocarriers for sorafenib.

Authors:  Valentina Giglio; Maurizio Viale; Vittorio Bertone; Irena Maric; Rita Vaccarone; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2017-11-08       Impact factor: 3.850

6.  Targeted delivery of paclitaxel by functionalized selenium nanoparticles for anticancer therapy through ROS-mediated signaling pathways.

Authors:  Guifang Gong; Bailing Fu; Caixin Ying; Zhiqin Zhu; Xiaoqian He; Yingying Li; Zhuanxing Shen; Qingshan Xuan; Yanqing Huang; Yan Lin; Yinghua Li
Journal:  RSC Adv       Date:  2018-11-30       Impact factor: 4.036

Review 7.  Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review.

Authors:  Roberta Balansin Rigon; Márcia Helena Oyafuso; Andressa Terumi Fujimura; Maíra Lima Gonçalez; Alice Haddad do Prado; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

8.  Synthetic strategies for the fluorescent labeling of epichlorohydrin-branched cyclodextrin polymers.

Authors:  Milo Malanga; Mihály Bálint; István Puskás; Kata Tuza; Tamás Sohajda; László Jicsinszky; Lajos Szente; Éva Fenyvesi
Journal:  Beilstein J Org Chem       Date:  2014-12-16       Impact factor: 2.883

9.  Polydisperse methyl β-cyclodextrin-epichlorohydrin polymers: variable contact time (13)C CP-MAS solid-state NMR characterization.

Authors:  Isabelle Mallard; Davy Baudelet; Franca Castiglione; Monica Ferro; Walter Panzeri; Enzio Ragg; Andrea Mele
Journal:  Beilstein J Org Chem       Date:  2015-12-30       Impact factor: 2.883

Review 10.  Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data.

Authors:  Cristina Scavone; Angela Colomba Bonagura; Sonia Fiorentino; Daniela Cimmaruta; Rosina Cenami; Marco Torella; Tiziano Fossati; Francesco Rossi
Journal:  Drugs R D       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.